title: Excessive antipsychotic dosing in a Canadian outpatient population.
authors.forename: Alasdair M
authors.initials: AM
authors.lastname: Barr
authors.forename: William J
authors.initials: WJ
authors.lastname: Panenka
authors.forename: William G
authors.initials: WG
authors.lastname: Honer
authors.forename: Sejal
authors.initials: S
authors.lastname: Khara
authors.forename: Ric M
authors.initials: RM
authors.lastname: Procyshyn
mesh_terms: D000553:Ambulatory Care / Q000706:statistics & numerical data*; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000188:drug therapy; D001955:British Columbia; D018680:Cholinergic Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004363:Drug Utilization / Q000706:statistics & numerical data; D058006:General Practice / Q000706:statistics & numerical data; D006801:Humans; D057970:Inappropriate Prescribing / Q000706:statistics & numerical data*; D009313:National Health Programs / Q000706:statistics & numerical data*; D011570:Psychiatry / Q000706:statistics & numerical data; D011618:Psychotic Disorders / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D018680:Cholinergic Antagonists